Study of Botulinum Toxin in Patients With Primary Hyperhidrosis

Mount Sinai Health System

Status: Completed

Conditions: Hyperhidrosis

Treatments: Drug: botulinum toxin type A

Study type: Interventional

Funder types: Other

Identifiers

NCT00004480

199/14182

ALLERGAN-MTS-GCO-98-913NE

MTS-GCO-98-913NE

Details and patient eligibility

About

OBJECTIVES:

I. Determine the optimal dose of botulinum toxin necessary to decrease sweating in patients with primary hyperhidrosis.

Full description

PROTOCOL OUTLINE:

Patients receive injections of botulinum toxin in the clinical trial for 6 months. Patients undergo an iodine starch test and a sympathetic skin response test to assess the efficacy of the drug. Patients also complete questionnaires to evaluate the amount of sweating.

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

• Diagnosis of hyperhidrosis
• Excessive sweating in the hands, feet, armpits, forehead, or body